John R. Liddicoat's most recent trade in Medtronic Plc was a trade of 6,543 Ordinary Shares done . Disclosure was reported to the exchange on July 29, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medtronic | John R. Liddicoat | EVP & President of Americas | Sale or transfer of securities back to the company at price $ 0.00 per share. | 29 Jul 2022 | 6,543 | 37,374 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. | 05 Nov 2021 | 139 | 42,998 (0%) | 0% | 123.0 | 17,094 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 28,641 | 28,641 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 8,381 | 8,381 | - | - | Performance Share Units | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 3,353 | 42,847 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. | 02 Aug 2021 | 3,258 | 39,494 (0%) | 0% | 131.3 | 427,808 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 1,085 | 1,085 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Sale of securities on an exchange or to another person at price $ 126.65 per share. | 28 May 2021 | 34,656 | 42,551 (0%) | 0% | 126.6 | 4,389,182 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 17,095 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. | 28 May 2021 | 17,095 | 59,646 (0%) | 0% | 78 | 1,333,410 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 15,142 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.06 per share. | 28 May 2021 | 15,142 | 77,207 (0%) | 0% | 88.1 | 1,333,405 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. | 28 May 2021 | 1,283 | 60,929 (0%) | 0% | 78 | 100,074 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 1,283 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2021 | 1,136 | 0 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.06 per share. | 28 May 2021 | 1,136 | 62,065 (0%) | 0% | 88.1 | 100,036 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.13 per share. | 03 Nov 2020 | 128 | 41,989 (0%) | 0% | 103.1 | 13,201 | Ordinary Shares |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 8,742 | 8,742 | - | - | Performance Share Units | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 39,672 | 39,672 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 35,894 | 35,894 | - | - | Stock Option (Right to Buy) | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 3,905 | 41,827 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | John R. Liddicoat | EVP & President of Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 1,575 | 1,575 | - | - | Stock Option (Right to Buy) |